110 related articles for article (PubMed ID: 34531315)
1. USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer.
Hou P; Ma X; Yang Z; Zhang Q; Wu CJ; Li J; Tan L; Yao W; Yan L; Zhou X; Kimmelman AC; Lorenzi PL; Zhang J; Jiang S; Spring D; Wang YA; DePinho RA
Genes Dev; 2021 Oct; 35(19-20):1327-1332. PubMed ID: 34531315
[TBL] [Abstract][Full Text] [Related]
2. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the pro-oncogenic c-RAF-PDE8A complex represents a differentiated approach to treating KRAS-c-RAF dependent PDAC.
Cooke SF; Wright TA; Sin YY; Ling J; Kyurkchieva E; Phanthaphol N; Mcskimming T; Herbert K; Rebus S; Biankin AV; Chang DK; Baillie GS; Blair CM
Sci Rep; 2024 Apr; 14(1):8998. PubMed ID: 38637546
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic dependency plays a dominant role in the immune response to cancer.
Li J; D'Amico S; Kirillov V; Petrenko O; Reich NC
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2308635120. PubMed ID: 37782788
[TBL] [Abstract][Full Text] [Related]
5. Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8
Mahadevan KK; LeBleu VS; Ramirez EV; Chen Y; Li B; Sockwell AM; Gagea M; Sugimoto H; Sthanam LK; Tampe D; Zeisberg M; Ying H; Jain AK; DePinho RA; Maitra A; McAndrews KM; Kalluri R
Dev Cell; 2023 Sep; 58(17):1562-1577.e8. PubMed ID: 37625403
[TBL] [Abstract][Full Text] [Related]
6. Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma.
Gulay KCM; Zhang X; Pantazopoulou V; Patel J; Esparza E; Pran Babu DS; Ogawa S; Weitz J; Ng I; Mose ES; Pu M; Engle DD; Lowy AM; Tiriac H
Cancer Res; 2023 Sep; 83(18):3001-3012. PubMed ID: 37378556
[TBL] [Abstract][Full Text] [Related]
7. Exploiting macropinocytosis for drug delivery into KRAS mutant cancer.
Liu H; Qian F
Theranostics; 2022; 12(3):1321-1332. PubMed ID: 35154489
[TBL] [Abstract][Full Text] [Related]
8. KRAS degradation averts PDAC chemoresistance.
Leonhardt L; Hebrok M
Nat Cancer; 2024 Mar; 5(3):375-377. PubMed ID: 38538908
[No Abstract] [Full Text] [Related]
9. Ectopic expression of DOCK8 regulates lysosome-mediated pancreatic tumor cell invasion.
Gutierrez-Ruiz OL; Johnson KM; Krueger EW; Nooren RE; Cruz-Reyes N; Heppelmann CJ; Hogenson TL; Fernandez-Zapico ME; McNiven MA; Razidlo GL
Cell Rep; 2023 Sep; 42(9):113042. PubMed ID: 37651233
[TBL] [Abstract][Full Text] [Related]
10. Screening Metabolic Biomarkers in
Liu Q; Lan J; Martínez-Jarquín S; Ge W; Zenobi R
Anal Chem; 2024 Mar; 96(12):4918-4924. PubMed ID: 38471062
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer.
Shi ZY; Li CY; Chen RY; Shi JJ; Liu YJ; Lu JF; Yang GJ; Chen J
Bioorg Chem; 2024 Jun; 147():107400. PubMed ID: 38688196
[TBL] [Abstract][Full Text] [Related]
12. Utilizing machine learning to identify nifuroxazide as an inhibitor of ubiquitin-specific protease 21 in a drug repositioning strategy.
Tak J; Nguyen TK; Lee K; Kim SG; Ahn HC
Biomed Pharmacother; 2024 May; 174():116459. PubMed ID: 38518599
[TBL] [Abstract][Full Text] [Related]
13. CYRI-B mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake.
Nikolaou S; Juin A; Whitelaw JA; Paul NR; Fort L; Nixon C; Spence HJ; Bryson S; Machesky LM
Elife; 2024 May; 13():. PubMed ID: 38712822
[TBL] [Abstract][Full Text] [Related]
14. Correction to "Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation".
Elechalawar CK; Rao G; Gulla SK; Patel MM; Frickenstein A; Means N; Roy RV; Tsiokas L; Asfa S; Panja P; Rao C; Wilhelm S; Bhattacharya R; Mukherjee P
ACS Nano; 2024 Mar; 18(12):9242. PubMed ID: 38465974
[No Abstract] [Full Text] [Related]
15. Anticipating resistance to KRAS inhibition: a novel role for USP21 in macropinocytosis regulation.
Crawford HC
Genes Dev; 2021 Oct; 35(19-20):1325-1326. PubMed ID: 34599002
[TBL] [Abstract][Full Text] [Related]
16. Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer.
Hanada K; Kawada K; Nishikawa G; Toda K; Maekawa H; Nishikawa Y; Masui H; Hirata W; Okamoto M; Kiyasu Y; Honma S; Ogawa R; Mizuno R; Itatani Y; Miyoshi H; Sasazuki T; Shirasawa S; Taketo MM; Obama K; Sakai Y
Cancer Lett; 2021 Dec; 522():129-141. PubMed ID: 34543685
[TBL] [Abstract][Full Text] [Related]
17. Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Cao L; Huang C; Cui Zhou D; Hu Y; Lih TM; Savage SR; Krug K; Clark DJ; Schnaubelt M; Chen L; da Veiga Leprevost F; Eguez RV; Yang W; Pan J; Wen B; Dou Y; Jiang W; Liao Y; Shi Z; Terekhanova NV; Cao S; Lu RJ; Li Y; Liu R; Zhu H; Ronning P; Wu Y; Wyczalkowski MA; Easwaran H; Danilova L; Mer AS; Yoo S; Wang JM; Liu W; Haibe-Kains B; Thiagarajan M; Jewell SD; Hostetter G; Newton CJ; Li QK; Roehrl MH; Fenyö D; Wang P; Nesvizhskii AI; Mani DR; Omenn GS; Boja ES; Mesri M; Robles AI; Rodriguez H; Bathe OF; Chan DW; Hruban RH; Ding L; Zhang B; Zhang H;
Cell; 2021 Sep; 184(19):5031-5052.e26. PubMed ID: 34534465
[TBL] [Abstract][Full Text] [Related]
18. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
[TBL] [Abstract][Full Text] [Related]
19. Antigen dominance hierarchies shape TCF1
Burger ML; Cruz AM; Crossland GE; Gaglia G; Ritch CC; Blatt SE; Bhutkar A; Canner D; Kienka T; Tavana SZ; Barandiaran AL; Garmilla A; Schenkel JM; Hillman M; de Los Rios Kobara I; Li A; Jaeger AM; Hwang WL; Westcott PMK; Manos MP; Holovatska MM; Hodi FS; Regev A; Santagata S; Jacks T
Cell; 2021 Sep; 184(19):4996-5014.e26. PubMed ID: 34534464
[TBL] [Abstract][Full Text] [Related]
20.
Maddipati R; Norgard RJ; Baslan T; Rathi KS; Zhang A; Saeid A; Higashihara T; Wu F; Kumar A; Annamalai V; Bhattacharya S; Raman P; Adkisson CA; Pitarresi JR; Wengyn MD; Yamazoe T; Li J; Balli D; LaRiviere MJ; Ngo TC; Folkert IW; Millstein ID; Bermeo J; Carpenter EL; McAuliffe JC; Oktay MH; Brekken RA; Lowe SW; Iacobuzio-Donahue CA; Notta F; Stanger BZ
Cancer Discov; 2022 Feb; 12(2):542-561. PubMed ID: 34551968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
